NM.C

TORONTO, ON / ACCESSWIRE / February 8, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that Prakash Gowd has been appointed as the Company's Chief Operating Officer (COO), replacing Pierre Bou-Mansour who is leaving the Company th... Read More...

TORONTO, ON / ACCESSWIRE / September 20, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has been included in the AdvisorShares Psychedelics ETF trading on the NYSE under the ticker "PSIL" (the "ETF").PSIL is the first U.S... Read More...

Samantha DeLenardo joins from CAMH, Canada's largest mental health teaching hospital and leader in mental health researchTORONTO, ON / ACCESSWIRE / August 6, 2021 /Novamind Inc., (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind"), leading mental health company specialized in psychedelic medicine, today announced the appointment of Samantha De... Read More...